E. Van Braeckel (Ghent, Belgium), A. Gramegna (Milano (MI), Italy)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Pathogenetic treatment of patients with new coronavirus infection COVID-19
L. Shovkun (Rostov-on-Don, Russian Federation), D. Kudlay (Moscow, Russian Federation), N. Nikolenko (Moscow, Russian Federation), E. Kampos (Rostov-on-Don, Russian Federation)
|   |
The first experience of anti-IL6 administration for COVID-19 infection
A. Vizel (Kazan (Republic of Tatarstan), Russian Federation), D. Abdulganieva (Kazan (Republic of Tatarstan), Russian Federation), A. Bayalieva (Kazan (Republic of Tatarstan), Russian Federation), I. Vizel (Kazan (Republic of Tatarstan), Russian Federation)
| |
A single centre study of COVID-19 patients: correlation with DDIMER and outcomes
I. Sau (Wolverhampton, United Kingdom), E. Qureshi (Wolverhampton, United Kingdom), M. Khalil (Wolverhampton, United Kingdom), S. Ejiofor (Wolverhampton, United Kingdom)
| |
Impact of viral load on mortality in hospitalized patients affected by Covid-19 infection.
C. De Pace (Foggia, Italy), D. Lacedonia (Foggia, Italy), G. Scioscia (Foggia, Italy), A. Del Colle (Foggia, Italy), E. Minenna (Foggia, Italy), M. De Carlo (Foggia, Italy), M. Palumbo (Foggia, Italy), M. Foschino-Barbaro (Foggia, Italy)
| |
Predicting role of coagulation parameters in Covid-19
S. Maazaoui (Tunis, Tunisia), I. Nouira (Tunis, Tunisia), S. Marzouki (Tunis, Tunisia), S. Habibech (Tunis, Tunisia), M. Chaabane (Tunis, Tunisia), H. Racil (Tunis, Tunisia), N. Chaouch (Tunis, Tunisia), i. nouira (monastir, Tunisia)
| |
Obesity in patients with COVID-19: is it a predictive factor for a poor prognosis?
R. Jebali (ARIANA, Tunisia), S. Louhaichi (ARIANA, Tunisia), I. Khalfallah (ARIANA, Tunisia), S. Elfidha (ARIANA, Tunisia), L. Kaabi (ARIANA, Tunisia), S. Marzouki (ARIANA, Tunisia), M. Kharrat (ARIANA, Tunisia), J. Ammar (ARIANA, Tunisia), B. Hamdi (ARIANA, Tunisia), A. Hamzaoui (ARIANA, Tunisia)
| |
Recovery from Respiratory Failure in Patients with COVID-19
M. Öz (Ankara, Turkey), S. Erol (Ankara, Turkey), A. Gürün Kaya (Ankara, Turkey), Ö. Isik (Ankara, Turkey), F. Çiftci (Ankara, Turkey), G. Çinar (Ankara, Turkey), Ç. Uzun (Ankara, Turkey), A. Azap (Ankara, Turkey), A. Kaya (Ankara, Turkey), Ö. Özdemir Kumbasar (Ankara, Turkey)
| |
Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19?
S. Louhaichi (Ariana, Tunisia), M. Ferchichi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), N. Boubaker (Ariana, Tunisia), S. Belkhir (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)
| |
Predictive factors for disease progression in moderate to severe COVID-19 patients
n. boubaker (Ariana, Tunisia), S. Louhaichi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), S. Belkhir (Ariana, Tunisia), M. Ferchichi (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)
| |
Does CT scan really predict severity in covid.19patients?
H. BAILI (mahdia, Tunisia), I. Touil (mahdia, Tunisia), J. Chelly (mahdia, Tunisia), A. Omrane (mahdia, Tunisia), S. Bouchareb (mahdia, Tunisia), J. Ayeb (mahdia, Tunisia), S. Kessissa (mahdia, Tunisia), F. Elaarbi (mahdia, Tunisia), L. Bouzgarrou (mahdia, Tunisia), N. Keskes Boudawara (mahdia, Tunisia), Y. Brahem (mahdia, Tunisia), J. Knani (mahdia, Tunisia), L. Boussoffara (mahdia, Tunisia)
| |
Characteristics of COVID-19 infection in diabetics
H. Snène (Tunis, Tunisia), W. Fenina (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), D. Belkhir (Tunis, Tunisia), M. Maalej (Tunis, Tunisia), I. El Wadhane (Tunis, Tunisia), A. Jebali (Tunis, Tunisia), A. Laater (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
| |
Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection.
A. Vianello (Padova (PD), Italy), F. Braccioni (Padova (PD), Italy), G. Guarnieri (Padova (PD), Italy), B. Molena (Padova (PD), Italy), A. Achille (Padova (PD), Italy), S. Lococo (Padova (PD), Italy), L. Salviati (Padova (PD), Italy), E. Crisafulli (Verona (VR), Italy), L. Bertagna De Marchi (Padova (PD), Italy), M. Caminati (Verona (VR), Italy), G. Senna (Verona (VR), Italy)
| |
Inflammatory biomarkers as predictors of intubation and mortality in severe COVID-19
D. García Estudillo (mexico, Mexico), Á. Vega-Sánchez (mexico, Mexico), J. Rojas-Serrano (mexico, Mexico), M. Mejía-Ávila (mexico, Mexico), H. Mateos-Toledo (mexico, Mexico), A. Estrada-Garrido (mexico, Mexico), J. Castillo-Pedroza (mexico, Mexico)
| |
Interleukin 6, as a « Target Molecule » ,in the Assessement of The Severity of SARS-2 COVID Infection
S. Daboussi (TUNIS, Tunisia), A. SAIDANE (TUNIS, Tunisia), S. Mhamdi (TUNIS, Tunisia), A. Riahi/bahri (TUNIS, Tunisia), I. Mejri (TUNIS, Tunisia), C. Aichaouia (TUNIS, Tunisia), Z. Moatameri (TUNIS, Tunisia), M. Khadhraoui (TUNIS, Tunisia)
| |
Dexamethasone in patients hospitalized with COVID-19: a NNT and NNH analysis of RECOVERY study
L. Calzetta (Parma (PR), Italy), M. Aiello (Parma (PR), Italy), P. Rogliani (Rome (RM), Italy), A. Chetta (Parma (PR), Italy)
| |
Halotherapy and Covid-19: an oppinion for a possible future prevention approach
R. Crisan-Dabija (Iasi (Iasi), Romania), C. Grigoras-Ichim (Iasi (Iasi), Romania), A. Luca (Iasi (Iasi), Romania), G. Sandu (Iasi (Iasi), Romania), D. Filipeanu (Iasi (Iasi), Romania)
| |
Experience of olokizumab use in COVID-19 patients
V. Antonov (Chelyabinsk (Chelyabinsk Oblast), Russian Federation), G. Ignatova (Chelyabinsk (Chelyabinsk Oblast), Russian Federation), S. Zotov (Chelyabinsk (Chelyabinsk Oblast), Russian Federation)
| |
The practice of empiric antibiotic therapy in patients with coronavirus disease 2019 (COVID-19).
O. Fesenko (Moscow, Russian Federation)
| |
Late Breaking Abstract - Correlation of CT severity score and Inflammatory markers to predict the disease severity in COVID 19 patients
A. Lonsane (Pune, India), R. Chopra (Pune, India), M. Jayamani (Chennai, India)
| |
Late Breaking Abstract - Covid Oximetry AT Home - A novel pandemic approach
M. Chandrashekar (Manchester, United Kingdom), K. Whelan (Manchester, United Kingdom), J. Wallace (Manchester, United Kingdom), S. Patel (Manchester , United Kingdom)
| |